Pharming Q2 EPS $0.02, Inline, Sales $90.200M Miss $100.625M Estimate
Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 66.67 percent decrease over earnings of $0.06 per share from the same period last year. The
Pharming made less profit per share than last year, and its sales fell short of what experts predicted. When a company's earnings drop and sales miss expectations, it's a sign to watch whether their business is slowing down.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.